Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.3162USD
−10.49 MUSD
3.10 M
About InVivo Therapeutics Holdings Corp
Sector
Industry
CEO
Richard Toselli
Website
Headquarters
Cambridge
Employees (FY)
6
Founded
2005
FIGI
BBG000MFKT69
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert S. Langer, Jr. in January 2005 and is headquartered in Cambridge, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NVIVQ is 0.3900 USD — it has decreased by 2.50% in the past 24 hours. Watch InVivo Therapeutics Holdings Corp stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange InVivo Therapeutics Holdings Corp stocks are traded under the ticker NVIVQ.
NVIVQ stock hasn't changed in a week, the month change is a 3.51% fall, over the last year InVivo Therapeutics Holdings Corp has showed a 70.23% decrease.
NVIVQ reached its all-time high on Jul 22, 2013 with the price of 465000.0000 USD, and its all-time low was 0.1500 USD and was reached on Mar 19, 2024. View more price dynamics on NVIVQ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NVIVQ stock is 2.56% volatile and has beta coefficient of 0.03. Track InVivo Therapeutics Holdings Corp stock price on the chart and check out the list of the most volatile stocks — is InVivo Therapeutics Holdings Corp there?
Today InVivo Therapeutics Holdings Corp has the market capitalization of 1.24 M, it has increased by 5.41% over the last week.
Yes, you can track InVivo Therapeutics Holdings Corp financials in yearly and quarterly reports right on TradingView.
InVivo Therapeutics Holdings Corp is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
NVIVQ net income for the last quarter is −2.70 M USD, while the quarter before that showed −1.94 M USD of net income which accounts for −39.24% change. Track more InVivo Therapeutics Holdings Corp financial stats to get the full picture.
No, NVIVQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 8, 2024, the company has 6.00 employees. See our rating of the largest employees — is InVivo Therapeutics Holdings Corp on this list?
Like other stocks, NVIVQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade InVivo Therapeutics Holdings Corp stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So InVivo Therapeutics Holdings Corp technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating InVivo Therapeutics Holdings Corp stock shows the sell signal. See more of InVivo Therapeutics Holdings Corp technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.